BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36142173)

  • 1. Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque.
    González-López P; Ares-Carral C; López-Pastor AR; Infante-Menéndez J; González Illaness T; Vega de Ceniga M; Esparza L; Beneit N; Martín-Ventura JL; Escribano Ó; Gómez-Hernández A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of miR-15a-5p and miR-199a-3p in the inflammatory pathway regulated by NF-κB in experimental and human atherosclerosis.
    González-López P; Álvarez-Villarreal M; Ruiz-Simón R; López-Pastor AR; de Ceniga MV; Esparza L; Martín-Ventura JL; Escribano Ó; Gómez-Hernández A
    Clin Transl Med; 2023 Aug; 13(8):e1363. PubMed ID: 37605307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis.
    Beneit N; Martín-Ventura JL; Rubio-Longás C; Escribano Ó; García-Gómez G; Fernández S; Sesti G; Hribal ML; Egido J; Gómez-Hernández A; Benito M
    Cardiovasc Diabetol; 2018 Feb; 17(1):31. PubMed ID: 29463262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-520c-3p targeting of RelA/p65 suppresses atherosclerotic plaque formation.
    Wang J; Hu X; Hu X; Gao F; Li M; Cui Y; Wei X; Qin Y; Zhang C; Zhao Y; Gao Y
    Int J Biochem Cell Biol; 2021 Feb; 131():105873. PubMed ID: 33166679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis.
    Su Y; Yuan J; Zhang F; Lei Q; Zhang T; Li K; Guo J; Hong Y; Bu G; Lv X; Liang S; Ou J; Zhou J; Luo B; Shang J
    Cell Death Dis; 2019 May; 10(5):365. PubMed ID: 31064980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5.
    Fu DN; Wang Y; Yu LJ; Liu MJ; Zhen D
    Exp Cell Res; 2021 Apr; 401(2):112519. PubMed ID: 33636159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-652-3p inhibition enhances endothelial repair and reduces atherosclerosis by promoting Cyclin D2 expression.
    Huang R; Hu Z; Cao Y; Li H; Zhang H; Su W; Xu Y; Liang L; Melgiri ND; Jiang L
    EBioMedicine; 2019 Feb; 40():685-694. PubMed ID: 30674440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis.
    Wei Y; Nazari-Jahantigh M; Chan L; Zhu M; Heyll K; Corbalán-Campos J; Hartmann P; Thiemann A; Weber C; Schober A
    Circulation; 2013 Apr; 127(15):1609-19. PubMed ID: 23513069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells.
    Chen W; Yu F; Di M; Li M; Chen Y; Zhang Y; Liu X; Huang X; Zhang M
    Atherosclerosis; 2018 Oct; 277():98-107. PubMed ID: 30193190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protective Effect of UBE2G2 Knockdown Against Atherosclerosis in Apolipoprotein E-Deficient Mice and Its Association with miR-204-5p.
    Liu Y; Luo Z; Wu Z; Liu K; Liang L; Wang C; Xu Y; Liang Y
    Mol Biotechnol; 2022 Sep; 64(9):1045-1054. PubMed ID: 35394254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis.
    Wiese CB; Zhong J; Xu ZQ; Zhang Y; Ramirez Solano MA; Zhu W; Linton MF; Sheng Q; Kon V; Vickers KC
    Atherosclerosis; 2019 Mar; 282():121-131. PubMed ID: 30731284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
    Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages.
    Yang S; Ye ZM; Chen S; Luo XY; Chen SL; Mao L; Li Y; Jin H; Yu C; Xiang FX; Xie MX; Chang J; Xia YP; Hu B
    J Mol Cell Cardiol; 2018 Oct; 123():139-149. PubMed ID: 30227118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-188-3p upregulation results in the inhibition of macrophage proinflammatory activities and atherosclerosis in ApoE-deficient mice.
    Zhang XF; Yang Y; Yang XY; Tong Q
    Thromb Res; 2018 Nov; 171():55-61. PubMed ID: 30253270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin Upregulates the Expression of miR-126 in Apolipoprotein E-knockout Mice with Carotid Atherosclerotic Plaque.
    Pan X; Hou R; Ma A; Wang T; Wu M; Zhu X; Yang S; Xiao X
    Cell Mol Neurobiol; 2017 Jan; 37(1):29-36. PubMed ID: 26886754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcoronary gradients of vascular miRNAs and coronary atherosclerotic plaque characteristics.
    Leistner DM; Boeckel JN; Reis SM; Thome CE; De Rosa R; Keller T; Palapies L; Fichtlscherer S; Dimmeler S; Zeiher AM
    Eur Heart J; 2016 Jun; 37(22):1738-49. PubMed ID: 26916800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNFα-Induced Insulin Resistance.
    Lozano-Bartolomé J; Llauradó G; Portero-Otin M; Altuna-Coy A; Rojo-Martínez G; Vendrell J; Jorba R; Rodríguez-Gallego E; Chacón MR
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1447-1458. PubMed ID: 29409019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MircoRNA-126-5p inhibits apoptosis of endothelial cell in vascular arterial walls via NF-κB/PI3K/AKT/mTOR signaling pathway in atherosclerosis.
    Jia W; Liu J; Tian X; Jiang P; Cheng Z; Meng C
    J Mol Histol; 2022 Feb; 53(1):51-62. PubMed ID: 34981408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.